Investors & Media

Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.

Latest News

Medigene appoints Axel-Sven Malkomes as CFO/CBDO

SHOW RELEASE

Medigene participates at four upcoming conferences

SHOW RELEASE

Additional European patent granted for Medigene's DC vaccine platform

SHOW RELEASE

The Medigene Share

The Medigene share MDG1 (ISIN:DE000A1X3W00 ) is listed at the Frankfurt Stock Exchange since June 2000. The share is part of SDAX, an index of the Deutsche Börse (German Stock Exchange) that includes Germany's most small-cap companies.

show medigene share

Reports & Presentations

2018

9 Months Report 2018

2019

Company Presentation January 2019

2018

Presentation on occasion of the 9 Months Report 2018

Annual General Meeting 2018

The Annual General Meeting of Medigene shareholders for fiscal year 2017 was held in German language on Tuesday, 15 May 2018 at "Haus der Bayerischen Wirtschaft", Max-Joseph-Straße 5, 80333 Munich, Germany.

read more

Corporate Governance

Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.

read more

Contact person

Julia Hofmann
Senior Director, Head of Public & Investor Relations
investor(at)medigene.com
public.relations(at)medigene.com
Telefon: +49-89-20 00 33-33 01
Fax: +49-89-20 00 33-29 20

Dr. Robert Mayer
Senior Manager Public & Investor Relations
investor(at)medigene.com
public.relations(at)medigene.com
Telefon: +49-89-20 00 33-33 01
Fax: +49-89-20 00 33-29 20